The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Contribution of bone microenvironment to leukemogenesis and leukemia progression
Open accessAbstract
Tumor microenvironment has a major role in cancer progression and resistance to treatment. The bone marrow (BM) is a dynamic network of growth factors, cytokines and stromal cells, providing a permissive environment for leukemogenesis and progression. Both BM stroma and leukemic blasts promote angiogenesis, which is increased in acute lymphoblastic leukemia and acute myeloid leukemia. Growth factors like vascular endothelial growth factor (VEGF), basic fibroblast growth factor and angiopoietins are the main proangiogenic mediators in acute leukemia. Autocrine proleukemic loops have been described for VEGF and angiopoietin in hematopoietic cells. Interactions of stromal cells and extracellular matrix with leukemic blasts can also generate antiapoptotic signals that contribute to neoplastic progression and persistence of treatment-resistant minimal residual disease. High expression of CXC chemokine ligand 4 (CXCR4) by leukemic blasts and activation of the CXCR4–CXCL12 axis is involved in leukemia progression and disruption of normal hematopoiesis. Leukemia-associated bone microenvironment markers could be used as prognostic or predictive indicators of disease progression and/or treatment outcome. Studies related to bone microenvironment would likely provide a better understanding of the treatment resistance associated with leukemia therapy and design of new treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Self-citationZlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,859
Stromal Gene Signatures in Large-B-Cell Lymphomas
Lenz, G., Wright, G., Dave, S. S., Xiao, W., Powell, J., Zhao, H., Xu, W., Tan, B., Goldschmidt, N., Iqbal, J., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802885 · Cited by 1,808
Rehman, J., Li, J., Orschell, C. M., & March, K. L. (2003) · Circulation · doi:10.1161/01.cir.0000058702.69484.a0 · Cited by 1,686
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment
Burger, J. A., & Kipps, T. J. (2006) · Blood · doi:10.1182/blood-2005-08-3182 · Cited by 1,170
Damiano, J. S., Cress, A. E., Hazlehurst, L. A., Shtil, A. A., & Dalton, W. S. (1999) · Blood · doi:10.1182/blood.v93.5.1658 · Cited by 901
In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment
Sipkins, D. A., Wei, X., Wu, J. W., Runnels, J. M., Côté, D., Means, T. K., Luster, A. D., Scadden, D. T., & Lin, C. P. (2005) · Nature · doi:10.1038/nature03703 · Cited by 878
Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia
Parmar, K., Mauch, P., Vergilio, J.-A., Sackstein, R., & Down, J. D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701152104 · Cited by 867
Yin, T. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28568 · Cited by 783
A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer
Farmer, P., Bonnefoi, H., Anderle, P., Cameron, D., Wirapati, P., Becette, V., André, S., Piccart, M., Campone, M., Brain, E., et al. (2009) · Nature Medicine · doi:10.1038/nm.1908 · Cited by 623
Matsunaga, T., Takemoto, N., Sato, T., Takimoto, R., Tanaka, I., Fujimi, A., Akiyama, T., Kuroda, H., Kawano, Y., Kobune, M., et al. (2003) · Nature Medicine · doi:10.1038/nm909 · Cited by 563
Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia.
Pérez‐Atayde, A. R., Sallan, S. E., Tedrow, U. B., Connors, S. L., Allred, E. N., & Folkman, J. (1997) · Europe PMC (PubMed Central) · Cited by 553
Colmone, A., Amorim, M., Pontier, A. L., Wang, S., Jablonski, E., & Sipkins, D. A. (2008) · Science · doi:10.1126/science.1164390 · Cited by 541
The Bone Marrow Microenvironment as a Tumor Sanctuary and Contributor to Drug Resistance
Meads, M. B., Hazlehurst, L. A., & Dalton, W. S. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2223 · Cited by 520
Folkman, J., & Kalluri, R. (2004) · Nature · doi:10.1038/427787a · Cited by 519
Self-citationZeng, Z., Xi Shi, Y., Samudio, I. J., Wang, R.-Y., Ling, X., Frolova, O., Levis, M., Rubin, J. B., Negrin, R. R., Estey, E. H., et al. (2009) · Blood · doi:10.1182/blood-2008-05-158311 · Cited by 518
Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia
Padró, T., Ruiz, S., Bieker, R., Bürger, H., Steins, M., Kienast, J., Büchner, T., Berdel, W. E., & Mesters, R. M. (2000) · Blood · doi:10.1182/blood.v95.8.2637 · Cited by 476
Evidence of increased angiogenesis in patients with acute myeloid leukemia
Hussong, J. W., Rodgers, G. M., & Shami, P. J. (2000) · Blood · doi:10.1182/blood.v95.1.309 · Cited by 474
CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers
Burger, J. A., & Peled, A. (2009) · Leukemia · doi:10.1038/leu.2008.299 · Cited by 462
Fiedler, W., Graeven, U., Ergün, S., Verago, S., Kilic, N., Stockschläder, M., & Hossfeld, D. K. (1997) · Blood · doi:10.1182/blood.v89.6.1870 · Cited by 437
Curti, A., Pandolfi, S., Valzasina, B., Aluigi, M., Isidori, A., Ferri, E., Salvestrini, V., Bonanno, G., Rutella, S., Durelli, I., et al. (2007) · Blood · doi:10.1182/blood-2006-07-036863 · Cited by 396
Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins
Konopleva, M., Konoplev, S., Hu, W., Zaritskey, A., Afanasiev, B., & Andreeff, M. (2002) · Leukemia · doi:10.1038/sj.leu.2402608 · Cited by 389
Tavor, S., Petit, I., Porozov, S., Avigdor, A., Dar, A., Leider-Trejo, L., Shemtov, N., Deutsch, V., Naparstek, E., Nagler, A., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3693 · Cited by 363
Martelli, A. M., Nyåkern, M., Tabellini, G., Bortul, R., Tazzari, P. L., Evangelisti, C., & Cocco, L. (2006) · Leukemia · doi:10.1038/sj.leu.2404245 · Cited by 342
Myelodysplastic syndromes: the complexity of stem-cell diseases
Corey, S. J., Minden, M. D., Barber, D. L., Kantarjian, H., Wang, J. C. Y., & Schimmer, A. D. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2047 · Cited by 342
Bellamy, W. T., Richter, L., Sirjani, D., Roxas, C., Glinsmann-Gibson, B., Frutiger, Y., Grogan, T. M., & List, A. F. (2001) · Blood · doi:10.1182/blood.v97.5.1427 · Cited by 342
Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase
Iwamoto, S., Mihara, K., Downing, J. R., Pui, C.-H., & Campana, D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30235 · Cited by 336
Oxygen saturation in the bone marrow of healthy volunteers
Harrison, J. S., Rameshwar, P., Chang, V., & Bandari, P. (2002) · Blood · doi:10.1182/blood.v99.1.394 · Cited by 328
Aguayo, A., Estey, E., Kantarjian, H., Mansouri, T., Gidel, C., Keating, M., Giles, F., Estrov, Z., Barlogie, B., & Albitar, M. (1999) · Blood · doi:10.1182/blood.v94.11.3717 · Cited by 319
Aguayo, A., Estey, E., Kantarjian, H., Mansouri, T., Gidel, C., Keating, M., Giles, F., Estrov, Z., Barlogie, B., & Albitar, M. (1999) · Blood · doi:10.1182/blood.v94.11.3717.423k09_3717_3721 · Cited by 299
Li, A., Varney, M. L., Valasek, J., Godfrey, M., Dave, B. J., & Singh, R. K. (2005) · Angiogenesis · doi:10.1007/s10456-005-5208-4 · Cited by 285
Microenvironment Determines Lineage Fate in a Human Model of MLL-AF9 Leukemia
Wei, J., Wunderlich, M., Fox, C., Alvarez, S., Cigudosa, J. C., Wilhelm, J. S., Zheng, Y., Cancelas, J. A., Gu, Y., Jansen, M., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.04.020 · Cited by 284
Dias, S., Hattori, K., Heissig, B., Zhu, Z., Wu, Y., Witte, L., Hicklin, D. J., Tateno, M., Bohlen, P., Moore, M. A. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191117498 · Cited by 268
Dias, S., Choy, M., Alitalo, K., & Rafii, S. (2002) · Blood · doi:10.1182/blood.v99.6.2179 · Cited by 250
Tumor microenvironment and angiogenesis
Nyberg, P. (2008) · Frontiers in Bioscience · doi:10.2741/3173 · Cited by 212
Padró, T., Bieker, R., Ruiz, S., Steins, M., Retzlaff, S., Bürger, H., Büchner, T., Kessler, T., Herrera, F., Kienast, J., et al. (2002) · Leukemia · doi:10.1038/sj.leu.2402534 · Cited by 197
Tabe, Y., Jin, L., Tsutsumi-Ishii, Y., Xu, Y., McQueen, T., Priebe, W., Mills, G. B., Ohsaka, A., Nagaoka, I., Andreeff, M., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3166 · Cited by 193
Zeng, Z., Samudio, I. J., Munsell, M., An, J., Huang, Z., Estey, E., Andreeff, M., & Konopleva, M. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0228 · Cited by 184
Blau, O., Hofmann, W.-K., Baldus, C. D., Thiel, G., Serbent, V., Schümann, E., Thiel, E., & Blau, I. W. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2006.10.012 · Cited by 171
Maxwell, P. H. (2005) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2005.03.001 · Cited by 167
Schuch, G., Machluf, M., Bartsch, G. C., Nomi, M., Richard, H., Atala, A., & Söker, S. (2002) · Blood · doi:10.1182/blood.v100.13.4622 · Cited by 160
Buggins, A. G. S., Milojković, D., Arno, M. J., Lea, N. C., Mufti, G. J., Thomas, N. S. B., & Hirst, W. J. R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.6021 · Cited by 155
Aguayo, Á., Kantarjian, H. M., Estey, E. H., Giles, F. J., Verstovšek, S., Manshouri, T., Gidel, C., O'Brien, S. M., Keating, M. J., & Albitar, M. X. (2002) · Cancer · doi:10.1002/cncr.10900 · Cited by 147
Does primary myelofibrosis involve a defective stem cell niche? From concept to evidence
Lataillade, J.-J., Pierre-Louis, O., Hasselbalch, H. C., Uzan, G., Jasmin, C., Martyré, M., & Bousse‐Kerdilès, M. L. (2008) · Blood · doi:10.1182/blood-2008-06-158386 · Cited by 146
Tumor Microenvironment and Angiogenesis
Davis, D. W., Herbst, R. S., & Abbruzzese, J. L. (2007) · CRC Press eBooks · doi:10.1201/9781420004298-10 · Cited by 145
Bradstock, K. F., & Gottlieb, D. J. (1995) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199509064917 · Cited by 137
Fiegl, M., Samudio, I. J., Clise-Dwyer, K., Burks, J. K., Mnjoyan, Z. H., & Andreeff, M. (2008) · Blood · doi:10.1182/blood-2008-06-161539 · Cited by 135
de Bont, E. S. J. M., Rosati, S., Jacobs, S. C., Kamps, W. A., & Vellenga, E. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02722.x · Cited by 111
Loges, S., Heil, G., Bruweleit, M., Schoder, V., Butzal, M., Fischer, U., Gehling, U. M., Schuch, G., HOSSFELD, D. K., & Fiedler, W. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.058 · Cited by 110
Papa, V., Tazzari, P. L., Chiarini, F., Cappellini, A., Ricci, F., Billi, A. M., Evangelisti, C., Ottaviani, E., Martinelli, G., Testoni, N., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404980 · Cited by 104
Quesenberry, P. J., & Aliotta, J. M. (2008) · Stem Cell Reviews and Reports · doi:10.1007/s12015-008-9036-y · Cited by 99
VLA-4-Mediated Interactions Between Normal Human Hematopoietic Progenitors and Stromal Cells
Oostendorp, R. A. J., & Dormer, P. G. (1997) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199709055581 · Cited by 98
A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospects
Wouters, B. J., Löwenberg, B., & Delwel, R. (2008) · Blood · doi:10.1182/blood-2008-04-153239 · Cited by 97
Evolving concepts on the microenvironmental niche for hematopoietic stem cells
Raaijmakers, M. H. G. P., & Scadden, D. T. (2008) · Current Opinion in Hematology · doi:10.1097/moh.0b013e328303e14c · Cited by 92
Bruserud, Ø., Ryningen, A., Wergeland, L., Glenjen, N. I., & Gjertsen, B. T. (2004) · PubMed · Cited by 86
Prognostic evaluation of the microvascular network in myelodysplastic syndromes
Korkolopoulou, P., Apostolidou, E., Pavlopoulos, P., Kavantzas, N., Vyniou, N., Thymara, I., Terpos, E., Patsouris, E., Yataganas, X., & Davaris, P. (2001) · Leukemia · doi:10.1038/sj.leu.2402220 · Cited by 84
Jensen, P. Ø., Mortensen, B. T., Hodgkiss, R. J., Iversen, P. O., Christensen, I. J., Helledie, N., & Larsen, J. K. (2000) · Cell Proliferation · doi:10.1046/j.1365-2184.2000.00183.x · Cited by 76
Winter, S. S., Sweatman, J. J., Lawrence, M. B., Rhoades, T. H., Hart, A. L., & Larson, R. A. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03182.x · Cited by 71
Ryningen, A., Wergeland, L., Glenjen, N. I., Gjertsen, B. T., & Bruserud, Ø. (2004) · Leukemia Research · doi:10.1016/j.leukres.2004.06.008 · Cited by 70
Antiangiogenesis in haematological malignancies
Li, W. W., Hutnik, M., & Gehr, G. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07372.x · Cited by 67
The role of the tumor microenvironment in hematological malignancies and implication for therapy
Zhou, J. (2005) · Frontiers in bioscience · doi:10.2741/1642 · Cited by 66
Changing bone marrow micro‐environment during development of acute myeloid leukaemia in rats
Mortensen, B. T., Jensen, P. Ø., Helledie, N., Iversen, P. O., Ralfkiaer, E. M., Larsen, J. K., & Madsen, M. T. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00801.x · Cited by 66
Leukemia-stimulated bone marrow endothelium promotes leukemia cell survival
Veiga, J. P., Costa, L. F., Sallan, S. E., Nadler, L. M., & Cardoso, A. A. (2006) · Experimental Hematology · doi:10.1016/j.exphem.2006.01.013 · Cited by 65
Scupoli, M. T., Perbellini, O., Krampera, M., Vinante, F., Cioffi, F., & Pizzolo, G. (2007) · Haematologica · doi:10.3324/haematol.10356 · Cited by 65
Scupoli, M. T., Donadelli, M., Cioffi, F., Rossi, M., Perbellini, O., Malpeli, G., Corbioli, S., Vinante, F., Krampera, M., Palmieri, M., et al. (2008) · Haematologica · doi:10.3324/haematol.12098 · Cited by 65
Keith, T. W., Araki, Y., Ohyagi, M., Hasegawa, M., Yamamoto, K., Kurata, M., Nakagawa, Y., Suzuki, K., & Kitagawa, M. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06539.x · Cited by 63
Wimazal, F., Krauth, M., Vales, A., Böhm, A., Agis, H., Sonneck, K., Aichberger, K. J., Mayerhofer, M., Simonitsch‐Klupp, I., Müllauer, L., et al. (2006) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190500353083 · Cited by 52
Porta, M. G. D., Malcovati, L., Rigolin, G. M., Rosti, V., Bonetti, E., Travaglino, E., Boveri, E., Gallì, A., Boggi, S., Ciccone, M., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2405069 · Cited by 46
Iversen, P., Sørensen, D., & Benestad, H. B. (2002) · Leukemia · doi:10.1038/sj.leu.2402376 · Cited by 46
Role of the microenvironment in promoting angiogenesis in acute myeloid leukemia
Litwin, C., Leong, K. G., Zapf, R., Sutherland, H. J., Naiman, S. C., & Karsan, A. (2002) · American Journal of Hematology · doi:10.1002/ajh.10092 · Cited by 45
Travaglino, E., Benatti, C., Malcovati, L., Porta, M. G. D., Gallì, A., Bonetti, E., Rosti, V., Cazzola, M., & Invernizzi, R. (2007) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2007.01012.x · Cited by 45
Kümpers, P., Koenecke, C., Hecker, H., Hellpap, J., Horn, R., Verhagen, W., Buchholz, S., Hertenstein, B., Krauter, J., Eder, M., et al. (2008) · Blood · doi:10.1182/blood-2007-12-130021 · Cited by 44
Antiangiogenic treatment with endostatin inhibits progression of AML in vivo
Schuch, G., Oliveira‐Ferrer, L., Loges, S., Laack, E., Bokemeyer, C., HOSSFELD, D. K., Fiedler, W., & Ergün, S. (2005) · Leukemia · doi:10.1038/sj.leu.2403824 · Cited by 42
Expression of endothelial cell-associated molecules in AML cells
Watarai, M., Miwa, H., Shikami, M., Sugamura, K., Wakabayashi, M., Satoh, A., Tsuboi, K., Imamura, A., Mihara, H., Katoh, Y., et al. (2002) · Leukemia · doi:10.1038/sj.leu.2402326 · Cited by 42
Brown, V. I., Seif, A. E., Reid, G. S. D., Teachey, D. T., & Grupp, S. A. (2008) · Immunologic Research · doi:10.1007/s12026-008-8038-9 · Cited by 41
Kim, D. H., Lee, N. Y., Lee, M., Sohn, S. K., Do, Y. R., & Park, J. Y. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06887.x · Cited by 38
Fibroblast nemosis arrests growth and induces differentiation of human leukemia cells
Kankuri, E. M., Babušíková, O., Hlubinova, K., Salmenperä, P., Boccaccio, C., Lubitz, W., Harjula, A. L. J., & Bízik, J. (2007) · International Journal of Cancer · doi:10.1002/ijc.23179 · Cited by 34
Lundberg, L. G., Hellström‐Lindberg, E., Kanter‐Lewensohn, L. R., Lerner, R., & Palmblad, J. E. W. (2005) · Leukemia Research · doi:10.1016/j.leukres.2005.07.003 · Cited by 30
Moshaver, B., van der Pol, M. A., Westra, A. H., Ossenkoppele, G. J., Zweegman, S., & Schuurhuis, G. J. (2008) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190701593636 · Cited by 23
Human B-cell progenitors and bone marrow microenvironment.
Campana, D., Coustan‐Smith, E., Manabe, A., KUMAGAI, M., Murti, K. G., Silvennoinen, O., Nishigaki, H., Kitanaka, A., & Ito, C. (1996) · PubMed · Cited by 20
Døsen, G., Munthe, E., Nygren, M. K., Stubberud, H., Hystad, M. E., & Rian, E. (2008) · International Journal of Cancer · doi:10.1002/ijc.23833 · Cited by 20
Pramanik, K., Trüpschuch, S., Greiner, A., Ruthardt, M., Henschler, R., & Müller, A. M. (2007) · Leukemia Research · doi:10.1016/j.leukres.2007.09.014 · Cited by 1
Cited by
Tumor microenvironment: Sanctuary of the devil
Hui, L., & Chen, Y. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.07.039 · Cited by 779
RNA Trafficking by Acute Myelogenous Leukemia Exosomes
Huan, J., Hornick, N. I., Shurtleff, M. J., Skinner, A. M., Goloviznina, N. A., Roberts, C. T., & Kurre, P. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2184 · Cited by 259
Bruce, A., Evans, R., Mezan, R., Shi, L., Moses, B. S., Martin, K. H., Gibson, L. F., & Yang, Y. (2015) · PLOS ONE · doi:10.1371/journal.pone.0140506 · Cited by 112
Abraham, M., Klein, S., Bulvik, B., Wald, H., Weiss, I. D., Olam, D., Weiss, L., Beider, K., Eizenberg, O., Wald, O., et al. (2017) · Leukemia · doi:10.1038/leu.2017.82 · Cited by 104
Metadata
- Authors
- Ayala, F., Dewar, R., Kieran, M., & Kalluri, R.
- Venue
- Leukemia
- Published
- 2009-09-03
- Volume
- 23
- Issue
- 12
- Pages
- 2233-2241
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- OpenAlex
- W1980952112
- Cited by
- 273
- References
- 82
- FWCI
- 17.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.